Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1996 Jun;87(6):623–630. doi: 10.1111/j.1349-7006.1996.tb00269.x

Inhibition of Natural Killer Cell Cytotoxicity by Cell Growth‐related Molecules

Yasuaki Tamura 1, Satoru Takashima 1, Joong‐Moon Cho 1, Weimin Qi 1, Kenjiro Kamiguchi 1, Toshihiko Torigoe 1, Shuji Takahashi 1, Itaru Hirai 1, Noriyuki Sato 1,✉, Kokichi Kikuchi 1
PMCID: PMC5921145  PMID: 8766527

Abstract

Certain MHC class I molecules on target cells are known to inhibit the cytotoxic action of NK cells. By using monoclonal antibody (mAb) Cho‐1, we have found inhibitory non‐MHC class I cell surface molecules that are noncovalently‐associated with 200 kDa and 40 kDa antigens. Poly I‐C‐induced rat NK cells were not cytotoxic to rat fetus‐derived fibroblast WFB cell line. In contrast, NK cells were cytotoxic to H‐ras oncogene‐induced transformants of WFB, W14 and W31. FACS analysis indicated that mAb Cho‐1 reacts with WFB, but not with W14 and W31 cells. Thus, this antigen may disappear concomitantly with cell growth and transformation. Cho‐1 antigens were also expressed on other NK‐resistant lines, such as mouse BALB3T3 fibroblast, EL‐4 lymphoma and human fibroblast HEPM. However, they were not expressed on NK‐sensitive mouse YAC‐1 and H‐ras transformant (Brash) of BALB3T3 cells. Furthermore, treatment of target cells with IFN‐γ clearly induced the cell surface expression of Cho‐1 antigens, and conferred a resistance to NK cytolysis on target cells. These data strongly suggest that Cho‐I antigen expression may correlate with target cell susceptibility to NK cells. Indeed, treatment of NK‐resistant WFB as well as HEPM cells with F(ab')2 fragments of mAb Cho‐1 resulted in the acquisition of susceptibility to NK cytolysis. Cho‐1 antigens may be novel molecules that regulate the NK resistance of cells.

Keywords: NK cell, Inhibitory molecule, MHC class I

Full Text

The Full Text of this article is available as a PDF (478.3 KB).

REFERENCES

  • 1. ) Cho , J. M. , Sato , N. , Yagihashi , A. , Konno , A. , Kara , I. , Konn , S. , Torigoe , T. , Qi , W. , Takashima , T. , Takahashi , N. and Kikuchi , K.Natural killer target molecules associated with the transformation of the oncogene‐transfected flbroblast . Cancer Res. , 51 , 4250 – 4256 ( 1991. ). [PubMed] [Google Scholar]
  • 2. ) Herberman , R. B. , Reynolds , C. W. and Ortaldo , J. R.Mechanisms of cytotoxicity by natural killer (NK) cells . Ann. Rev. Immunol. , 4 , 651 – 658 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Trinchieri , G.Biology of natural killer cells . Adv. Immunol. , 47 , 187 – 376 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. ) Welsh , R. M. , Barbaker , J. Q. , Vargas‐Cortes , M. and O'Donnell , C. L.Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency: the stimulation of NK cells and the NK cell‐dependent control of virus infections occur independently of T and B cell functions . J. Exp. Med. , 173 , 1053 – 1063 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Hofer , E. , Duchler , M. , Fuad , S. A. , Houchins , J. P. , Yabe , T. and Bach , F. H.Candidate natural killer cell receptors . Immunol. Today , 13 , 429 – 430 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Ryan , J. C. , Niemi , E. C. , Goldfien , R. D. , Hiserodt , J. C. and Seaman , W. E.NKR‐P1, an activating molecule on rat natural killer cells, stimulates phosphoinositide turnover and a rise in intracellular calcium . J. Immunol. , 147 , 3244 – 3250 ( 1991. ). [PubMed] [Google Scholar]
  • 7. ) Ryan , J. C. , Turck , J. , Niemi , E. C. , Yokoyama , W. M. and Seaman , W. E.Molecular cloning of the NK1.1 antigen, a member of the NKR‐P1 family of natural killer cell activation molecules . J. Immunol. , 149 , 1631 – 1635 ( 1992. ). [PubMed] [Google Scholar]
  • 8. ) Houchins , J. P. , Yabe , T. , McSherry , C. and Bach , F. H.DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells . J. Exp. Med. , 173 , 1017 – 1020 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Yokoyama , W. M. , Ryan , J. C. , Hunter , J. J. , Smith , H. R. C. , Stark , M. and Seaman , W. E.cDNA cloning of mouse NKR‐P1 and genetic linkage with Ly49. Identification of a natural killer cell gene complex on mouse chromosome 6 . J. Immunol. , 147 , 3229 – 3236 ( 1991. ). [PubMed] [Google Scholar]
  • 10. ) Yagihashi , A. , Sato , N. , Torigoe , T. , Okubo , M. , Konno , A. , Takahashi , N. , Yamashita , T. , Fujinaga , K. , Kuzumaki , N. and Kikuchi , K.Identification of the transformation‐associated cell surface antigen expressed on the rat fetus‐derived fibroblast . Cancer Res. , 48 , 2798 – 2804 ( 1988. ). [PubMed] [Google Scholar]
  • 11. ) Sato , N. , Cho , J. M. , Takashima , T. , Tsuboi , N. , Nihei , T. , Wada , Y. and Kikuchi , K.Immunogenicity and involvement in the host's effector mechanisms of the oncogene‐induced transformation‐associated cell surface antigens . In Vivo , 5 , 663 – 670 ( 1991. ). [PubMed] [Google Scholar]
  • 12. ) Kärre , K.Express yourself or die: peptides, MHC molecules, and NK cells . Science , 267 , 978 – 979 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Leibson , P. J.MHC‐recognizing receptors: they're not just for T cells anymore . Immunity , 3 , 5 – 8 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Malnati , M. S. , Peruzzi , M. , Parker , K. C. , Biddison , W. E. , Ciccone , E. , Moretta , A. and Long , E. O.Peptide specificity in the recognition of MHC class I by natural killer clones . Science , 267 , 1016 – 1018 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Storkus , W. J. and Dawson , J. R.Target structures involved in natural killing (NK): characteristics, distribution, and candidate molecules . CRC Crit. Rev. Immunol. , 10 , 393 – 415 ( 1991. ). [PubMed] [Google Scholar]
  • 16. ) Liao , N. H. , Bix , M. , Zijlstra , M. , Jaenisch , R. and Raulet , D.MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity . Science , 253 , 199 – 202 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Kaufman , D. S. , Schoon , R. A. and Leibson , P. J.MHC class I expression on tumor targets inhibits natural killer cell‐mediated cytotoxicity without interfering with target recognition . J. Immunol. , 150 , 1429 – 1436 ( 1993. ). [PubMed] [Google Scholar]
  • 18. ) Glas , R. , Sturmhofel , K. , Hämmerling , G. J. , Kärre , K. and Ljunggren , H. J.Restoration of a tumorigenic phenotype by β2‐microglobin transfection to EL‐4 mutant cells . J. Exp. Med. , 175 , 843 – 846 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Storkus , W. J. , Salter , R. D. , Cressweil , P. and Dawson , J. R.Peptide‐induced modulation of target cell sensitivity to natural killing . J. Immunol. , 149 , 1185 – 1190 ( 1992. ). [PubMed] [Google Scholar]
  • 20. ) Salcedo , M. , Momburg , F. , Hammerling , G. L. and Ljunggren , H. G.Resistance to natural killer cell lysis conferred by TAP 1/2 genes in human antigen‐processing mutant cells . J. Immunol. , 152 , 1702 – 1708 ( 1994. ). [PubMed] [Google Scholar]
  • 21. ) Karlhofer , F. M. , Ribuado , R. K. and Yokoyama , W. M.MHC class I alloantigen specificity of Ly‐49+ IL‐2‐activated natural killer cells . Nature , 358 , 66 – 70 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Kane , K. P.Ly‐49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules . J. Exp. Med. , 179 , 1011 – 1015 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Qi , W. , Tamura , Y. , Takashima , S. , Sato , N. and Kikuchi , K.Transformation‐associated 86 kDa natural killer target molecule expressed on the mouse, rat and human cell surface . Jpn. J. Cancer Res. , 85 , 862 – 868 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Tamura , Y. , Tsuboi , N. , Sato , N. and Kikuchi , K.70 kDa heat shock cognate protein is a transformation‐associated antigen and a possible target for the hosts' anti‐tumor immunity . J. Immunol. , 151 , 5516 – 5524 ( 1993. ). [PubMed] [Google Scholar]
  • 25. ) Konno , A. , Sato , N. , Yagihashi , A. , Torigoe , T. , Cho , J. M. , Torimoto , K. , Kara , L. , Wada , Y. , Okubo , M. , Takahashi , N. and Kikuchi , K.Heat‐ or stress‐inducible transformation‐associated cell surface antigen on the activated H‐ras oncogene‐transfected rat fibroblast . Cancer Res. , 49 , 6578 – 6582 ( 1989. ). [PubMed] [Google Scholar]
  • 26. ) Torigoe , T. , Sato , N. , Takashima , T. , Cho , J. M. , Tsuboi , N. , Qi , W. , Hara , L. , Wada , Y. , Takahashi , N. and Kikuchi , K.Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes . J. Immunol. , 147 , 3251 – 3258 ( 1991. ). [PubMed] [Google Scholar]
  • 27. ) Okubo , M. , Sato , N. , Wada , Y. , Takahashi , S. , Torimoto , K. , Takahashi , N. , Sato , T. , Okazaki , M. , Asaishi , K. and Kikuchi , K.Identification by monoclonal antibody of the tumor antigen of a human autologous breast cancer cell that is involved in cytotoxicity by a cytotoxic T‐cell clone . Cancer Res. , 49 , 3950 – 3954 ( 1989. ). [PubMed] [Google Scholar]
  • 28. ) Parham , P.On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice . J. Immunol. , 131 , 2895 – 2902 ( 1984. ). [PubMed] [Google Scholar]
  • 29. ) Matsuura , A. , Ishii , Y. , Iwaki , H. and Kikuchi , K.A novel cell surface antigen expressed on most leucocytes and a minor cortisone resistant population of thymocytes in rats: characterization by monoclonal antibodies . Microbiol, Immunol. , 29 , 873 – 881 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Coligan , J. E. , Kruisbeel , A. M. , Margulies , D. H. , Shevach , E. M. and Strober , W.Fragmentation of IgM to F(ab')2μ and F(ab')μ . In “ Current Protocols in Immunology ,” pp. 2.10.1 – 2.10.4 ( 1992. ). Wiley Interscience; , New York . [Google Scholar]
  • 31. ) Storkus , W. J. , Salter , R. D. , Alexander , J. , Ward , F. E. , Ruiz , R. E. , Cresswell , P. and Dawson , J. R.Class I‐induced resistance to natural killing: identification of nonpermissive residues in HLA‐A2 . Proc. Natl. Acad. Sci. , 88 , 5989 – 5992 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. ) Moretta , L. , Ciccone , E. , Moretta , A. , Höglund , P. , Öhlen , C. and Kärre , K.Allorecognition by NK cells: nonself or no self ? Immunol. Today , 13 , 300 – 306 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Charwick , B. S. and Miller , R. G.Hybrid resistance in vitro. Possible role of both class I and self peptides in determining the level of target cell susceptibility . J. Immunol. , 148 , 2307 – 2313 ( 1992. ). [PubMed] [Google Scholar]
  • 34. ) Chadwick , B. S. , Sambhara , S. R. , Sasakura , Y. and Miller , R. G.Effect of class I MHC binding peptides on recognition by natural killer cells . J. Immunol. , 149 , 3150 – 3156 ( 1992. ). [PubMed] [Google Scholar]
  • 35. ) Hamesath , T. J. , Marlon , L. S. and Stefansson , K.Inhibition of T cell activation by the extracellular matrix protein tenascin . J. Immunol. , 152 , 5199 – 5207 ( 1994. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES